DAVID EMERSON JORDEN Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for DAVID EMERSON JORDEN.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of DAVID EMERSON JORDEN. DAVID EMERSON JORDEN is a Acting CFO in Nuo Therapeutics, Inc. ($NUOT) and a CEO and CFO in Nuo Therapeutics, Inc. ($NUOT) and a CEO, CFO in Nuo Therapeutics, Inc. ($NUOT) and a Director in Nuo Therapeutics, Inc. ($NUOT) and a Acting Chief Financial Officer in PLx Pharma Inc. ($DPRX).

Address: 416 HUNGERFORD DRIVE SUITE 330 ROCKVILLE 20850 MD

Companies in which DAVID EMERSON JORDEN is an Insider

Nuo Therapeutics, Inc.

Trading Symbol: AURX
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of DAVID EMERSON JORDEN: CEO, CFO, CEO and CFO, Acting CFO, Director
Holdings: 557,146 shares
Current Value: $5,571
Latest Transaction: Jan 03 2019
$AURX Market Capitalization: $1.82M
$AURX Previous Close: $0.01

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

PLx Pharma Inc.

Trading Symbol: PLXP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID EMERSON JORDEN: Acting Chief Financial Officer
Holdings: 151,913 shares
Current Value: $205,083
Latest Transaction: Jun 16 2017
$PLXP Market Capitalization: $15.01M
$PLXP Previous Close: $1.35

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of DAVID EMERSON JORDEN

Sentiment: All, AURX, PLXP

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 03 2019AURXNuo Therapeutics, ...JORDEN DAVID EMERSONCEO, CFOOption ExerciseA0.40125,00050,000125,000
Aug 13 2018AURXNuo Therapeutics, ...JORDEN DAVID EMERSONCEO, CFOOption ExerciseA0.40192,71077,084192,710
Aug 14 2017NUOTNuo Therapeutics, ...JORDEN DAVID EMERSONCEO, CFOBuyP0.22247,50054,995557,146309.6 K to 557.1 K (+79.93 %)
Jun 16 2017DPRXPLx Pharma Inc.JORDEN DAVID EMERSONActing Chief Financ ...Option ExerciseP7.5032,727245,45332,727
Jun 16 2017DPRXPLx Pharma Inc.JORDEN DAVID EMERSONActing Chief Financ ...BuyP6.8832,727224,998151,913119.2 K to 151.9 K (+27.46 %)
Apr 20 2017DPRXPLx Pharma Inc.JORDEN DAVID EMERSONActing Chief Financ ...Option ExerciseA12.4433,753419,88733,753
Apr 20 2017DPRXPLx Pharma Inc.JORDEN DAVID EMERSONActing Chief Financ ...GrantA0.00119,1860119,1860 to 119.2 K

View all DAVID EMERSON JORDEN insider transactions.